Noxilizer, Inc. and SAIAN Corporation announced today Noxilizer’s asset acquisition of SAIAN Corporation. Both companies have been involved in developing nitrogen dioxide as a sterilization solution for pharmaceutical, biotech and medical device companies, as well as hospitals. The strategic acquisition is intended to strengthen the global effort to promote acceptance and growth of nitrogen dioxide sterilization as a powerful and less-expensive alternative to current sterilization methods.

Nitrogen dioxide (NO2) sterilization technology represents one of the more important innovations in medical device sterilization in over 20 years. As a low temperature sterilization alternative to ethylene oxide (EO), gamma and hydrogen peroxide, Noxilizer provides an option for companies to save significant costs by safely sterilizing in house, allowing inventory release in just hours versus days. Other benefits provided by nitrogen dioxide sterilization include: a true room temperature process, improved materials compatibility, much faster cycle time and no concerns about residuals. All important factors as pharmaceutical, biotech and medical device companies continue to innovate and grow.

For the press release, please look at the following.
http://www.noxilizer.com/